Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.4%

1 terminated out of 42 trials

Success Rate

96.7%

+10.2% vs benchmark

Late-Stage Pipeline

12%

5 trials in Phase 3/4

Results Transparency

3%

1 of 29 completed with results

Key Signals

1 with results97% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (23)
P 1 (1)
P 2 (2)
P 3 (2)
P 4 (3)

Trial Status

Completed29
Unknown6
Recruiting3
Not Yet Recruiting2
Withdrawn1
Terminated1

Trial Success Rate

96.7%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT06513026Not ApplicableRecruitingPrimary

Milk for Diabetes Prevention

NCT07494123Not ApplicableCompleted

Lactase Enzyme Supplementation for Growth and Feeding Tolerance in Preterm Infants

NCT06931379Not Yet RecruitingPrimary

Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant

NCT06177938Not ApplicableRecruitingPrimary

Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers

NCT06617364Not ApplicableCompletedPrimary

MSOT for Assessment of Intestinal Transit Time in Lactose Intolerance Patients

NCT06789068Not ApplicableCompletedPrimary

Lactose Intolerance in Infants With Gastrointestinal Disturbances

NCT06773650Recruiting

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

NCT06107088Not ApplicableCompletedPrimary

Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance

NCT04531033Not ApplicableCompletedPrimary

Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo

NCT03860051CompletedPrimary

Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.

NCT05669274Not ApplicableUnknownPrimary

Comparing the Adaptation of Commercial Milk and A2 Milk in Lactose Maldigesters

NCT01129791Not ApplicableCompletedPrimary

Effects of Raw Versus Other Milk Sources on Lactose Digestion

NCT05668468Not ApplicableUnknownPrimary

A Bifido Bacteria to Improve Lactose Digestion and Tolerance

NCT05660278Not ApplicableUnknownPrimary

Comparing the Inflammation, Maldigestion and Symptoms Due to Commercial Milk and A2 Milk

NCT05367453Not ApplicableCompletedPrimary

Effect of a Probiotic With High Beta-galactosidase Activity on Patients With Lactose Intolerance

NCT05100719Not ApplicableNot Yet Recruiting

The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)

NCT04754724Not ApplicableCompletedPrimary

Evaluation of GIMate Handheld Hydrogen Breath Monitor for Diagnosis of Lactose Malabsorption

NCT02085889Unknown

Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders

NCT02703987Not ApplicableCompletedPrimary

HYBRID: Hydrogen Breath Test in Lactose Digestion

NCT03261856Completed

Clinical Utility of Breath Tests in GI

Scroll to load more

Research Network

Activity Timeline